Caricamento...
Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
Breast cancer stem cells (BCSCs), also known as breast cancer initiating cells, are reported to be responsible for the initiation, progression, therapeutic resistance, and relapse of breast cancer. Conventional therapeutic agents mainly kill the bulk of breast tumor cells and fail to eliminate BCSCs...
Salvato in:
| Pubblicato in: | Int J Nanomedicine |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914063/ https://ncbi.nlm.nih.gov/pubmed/33654398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S282110 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|